Sign In  |  Register  |  About Sunnyvale  |  Contact Us

Sunnyvale, CA
September 01, 2020 10:10am
7-Day Forecast | Traffic

  • Search Hotels in Sunnyvale

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Merck & Co (NY: MRK )

110.12 +1.28 (+1.18%)
Official Closing Price Updated: 7:00 PM EST, Nov 30, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 20,305,813
Open 108.70
Bid (Size) 109.78 (1)
Ask (Size) 110.00 (19)
Prev. Close 108.84
Today's Range 107.63 - 110.33
52wk Range 71.50 - 110.33
Shares Outstanding 2,531,374,696
Dividend Yield 2.36%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Merck Announces First-Quarter 2023 Dividend
From Merck & Co., Inc.
Via Business Wire

Performance

YTD
+43.25%
+43.25%
1 Month
+8.81%
+8.81%
3 Month
+29.01%
+29.01%
6 Month
+20.83%
+20.83%
1 Year
+47.00%
+47.00%

More News

Read More
3 Dow Stocks to Take Seriously in 2023
Via InvestorPlace
Cramer Expects Dow's Outperformance To Last 'Longer' As Traders Chase 'Old-Fashioned, Profitable' Companies Amid Uncertainty
Via Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,100 Today
Via Benzinga
Merck's Keytruda Phase 3 Trial Meets Primary Endpoint In Gastric Cancer Patients
Via Benzinga
3 Reasons Pfizer Stock Will Crush the Broader Market in 2023
Via The Motley Fool
Stocks Take A Hit As Wall Street Eyes China Covid Unrest
Via Talk Markets
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Merck & Co Unusual Options Activity
Via Benzinga
2 Biotech Stocks You Can Buy and Hold for the Next Decade
Via The Motley Fool
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
3 Biotech Stocks Smart Investors Should Be Buying Up Now
Via InvestorPlace
7 Stocks on the Perfect 10 List
Via InvestorPlace
Mirati Therapeutics Surges As Big Pharma Reportedly Preps For A Buyout Battle
Via Investor's Business Daily
See Why Gilead's Cancer Business Is Driving The Stock To A Fever Pitch
Via Investor's Business Daily
Mirati Therapeutics Garners Interest From Large Pharmas Ahead Of Much Awaited Data Next Month
Via Benzinga
10-Year Phase 3 Trial Shows CEL-SCI's Multikine immunotherapy Extends Lives In Head & Neck Cancer Patients
Via Benzinga
First Patients Dosed in Phase I/II Trial of Enlivex's Off-the-Shelf Cell Therapy Candidate, AllocetraTM
Via Benzinga
Merck Announces Phase 3 KEYNOTE-859 Trial Met Primary Endpoint of Overall Survival in Patients With HER2-Negative Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
From Merck & Co., Inc.
Via Business Wire
Analyst Says IO Biotech's Cancer Treatment Approach 'Differentiated'
Via Benzinga
OPEC Rumors, Energy Stocks Drag Wall Street
Via Talk Markets
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Merck & Co Unusual Options Activity For November 21
Via Benzinga
Imago BioSciences (NASDAQ: IMGO) to be Acquired by Merck (NYSE: MRK) for $1.35 Billion
Via Spotlight Growth
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Sunnyvale.com & California Media Partners, LLC. All rights reserved.